20 citations
,
August 2019 in “Expert Opinion on Drug Safety” This review examines the cognitive effects of medications for lower urinary tract symptoms and indicates that muscarinic antagonists, particularly oral oxybutynin, pose the highest risk for cognitive impairment.
16 citations
,
February 2009 in “Clinical neurology and neurosurgery” In this study, patients with epilepsy who switched from immediate-release to extended-release divalproex sodium did not experience significant changes in seizure frequency, but most preferred the new formulation due to a subjective decrease in tremor during daily activities.
14 citations
,
March 2007 in “Pediatric pulmonology” This study found evidence suggesting that hypertrichosis may be an adverse effect of inhaled corticosteroids in children, although it does not always resolve after stopping treatment.
13 citations
,
December 2024 in “Cellular and Molecular Life Sciences” This study reviews recent advancements in understanding caspases, highlighting their roles beyond apoptosis in cancer, inflammation, and neurological disorders, and discusses the potential and challenges of targeting caspases for therapeutic purposes.
11 citations
,
December 2017 in “Journal of the American Academy of Dermatology” This letter highlights that levonorgestrel intrauterine devices may lead to fewer systemic side effects, like acne, compared to its oral administration due to lower systemic levels of progestogens.
9 citations
,
August 2006 in “American Journal of Psychiatry” This case report suggests that lamotrigine treatment may be associated with hair loss as a rare side effect, based on the observation of hair regrowth after discontinuation of the drug in a single patient.
8 citations
,
December 2006 in “Journal of Vascular Surgery” Foam sclerotherapy for varicose veins may cause unexpected hair growth.
7 citations
,
August 2000 in “Journal of Pediatric and Adolescent Gynecology” This review discusses perceptions and side effects of depot medroxyprogesterone acetate and emphasizes the importance of educating teens to enhance compliance; it reports no new clinical findings.
6 citations
,
October 2016 in “Journal of Chemotherapy” This case report describes a rare instance of alopecia universalis occurring eight weeks after discontinuing pegylated interferon α and ribavirin therapy, highlighting the need for awareness among healthcare providers.
4 citations
,
October 2021 in “Canadian Journal of Physiology and Pharmacology” This study observed that female pancreatic cancer patients were more likely to experience specific chemotherapy side effects, while younger patients generally faced lower toxicity risks.
4 citations
,
October 2019 in “Skin Appendage Disorders” This case report describes the first known instance of hair and eyebrow hyperpigmentation in a patient after seven months of gefitinib treatment for non-small cell lung cancer.
4 citations
,
January 2019 in “PubMed” This study found that low dose valproate monotherapy in epileptic children commonly leads to side-effects like weight gain and decreased appetite, especially among younger patients.
4 citations
,
March 1989 in “PubMed” This article discusses the side effects of radiation therapy on specific body areas and offers guidance on patient management, but it introduces no new results.
3 citations
,
January 2015 in “Clinical and Experimental Dermatology” This article discusses a serious side effect associated with a potentially widely used cosmetic product but reports no new experimental results.
3 citations
,
February 2013 in “The Journal of Sexual Medicine” In this article, Irwig reported that sexual side effects of finasteride persist in 96% of patients even after stopping the medication, raising concerns about potential permanence.
2 citations
,
March 2015 in “Clinical and Experimental Dermatology” This article addresses an unusual side effect of azathioprine but provides no abstract or detailed results, focusing instead on a specific dermatological perspective.
1 citations
,
January 2024 in “Revista CUIDARTE” This abstract discusses research into various interventions like acupressure, massage, and music therapy for managing secondary symptoms such as nausea, pain, and neuropathy. The authors emphasized the need for standardizing these interventions and their outcome measurements.
1 citations
,
October 2023 In this study, the authors found that syntax-based neural networks performed comparably to pre-trained Transformers on tasks involving definitely unseen sentences, suggesting they are a more transparent and parameter-efficient alternative for certain Natural Language Processing applications.
1 citations
,
May 2023 in “Jurnal Kedokteran Diponegoro” This study examined the most common chemotherapy side effects among patients with prostate, bladder, and testicular cancer, noting hair loss, fatigue, and decreased appetite as frequent symptoms.
1 citations
,
July 2006 in “American Journal of Psychiatry” This case report describes a probable connection between lamotrigine treatment and hair loss, resolving upon discontinuation, suggesting alopecia as a rare side effect of the drug.
1 citations
,
June 1979 in “The Journal of Dermatologic Surgery and Oncology” Doctors successfully rebuilt a sideburn using skin and hair from near the ear in one surgery.
June 2026 in “British Journal of Dermatology” This review highlights how serendipitous drug discoveries have significantly advanced dermatology by repurposing existing medications for new therapeutic uses through careful clinical observation and investigation.
April 2025 in “European Psychiatry” This systematic review and meta-analysis found that mood stabilizers used for bipolar disorder, such as lithium, valproate, carbamazepine, and lamotrigine, resulted in varying prevalence of dermatologic side effects, with lamotrigine showing the highest rash incidence, while severe reactions were rare.
January 2025 in “Scholars Journal of Medical Case Reports” In this study, a 37-year-old Moroccan man experienced hair loss after two months of quetiapine treatment for major depressive disorder, which resolved after discontinuation, highlighting the need for awareness of this potential rare side effect.
November 2024 in “International Medical Case Reports Journal” Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.
October 2024 in “Skin Appendage Disorders” This study found no overall side preference for hair growth on the scalp, yet many healthy individuals tend to grow more hair on one side, suggesting that genetics and possibly behavioral or environmental factors may influence this pattern.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
May 2024 in “International journal of medicine and psychology.” This study explored the issue of teenage pregnancies and underage mothers, focusing on providing psychological assistance and social support, and proposed measures for prevention and support using an interdisciplinary approach within the context of state demographic policy.
May 2024 in “Indian Journal of Pharmacology” In this case report, an 11-year-old girl with alopecia totalis initially treated with minoxidil experienced hypertrichosis, which reversed upon stopping the medication; hair regrowth on the scalp was achieved with tofacitinib after minoxidil discontinuation.
This study observed that women using combined oral contraceptives experienced more nausea, vomiting, and hair loss, while those on Depo-Provera were more likely to gain weight.